Hoechst Marion to launch latest anti-TB drug in India
Submitted by ipsita on Wed, 1997-12-17 10:30
Refapentine, the first new anti-TB drug on the global healtcare horizon after 30 years, was recently approved by the US Food and Drug Administration (FDA) for pulmonary tuberculosis.
Main Topic:
Mark Content Private(Internal):
Clipping Type:
DNB
External URL:
Main Type:
dte-DNB
Publication Date:
17/12/1997